Results 151 to 160 of about 9,189 (185)

The Effectiveness of Aztreonam, Aztreonam-Avibactam, Cefiderocol on blaNDM-Producing E. coli Isolates

open access: yesMolecular Genetics, Microbiology and Virology
Objectives: The study aimed to evaluate the effectiveness of aztreonam, aztreonam-avibactam, cefiderocol, and cefiderocol-avibactam against numerous New Delhi Metallo-beta-Lactamase-producing E.
Abdullah Tozluyurt
exaly   +3 more sources

Validation of Aztreonam-Avibactam Susceptibility Testing Using Digitally Dispensed Custom Panels

open access: yesJournal of Clinical Microbiology, 2020
Aztreonam-avibactam is a combination antimicrobial agent with activity against carbapenemase-producing Enterobacteriaceae (CPE) with metallo-β-lactamases (MβLs). Although aztreonam-avibactam is not yet approved by the U.S.
Eric Ransom   +2 more
exaly   +4 more sources

Activity of aztreonam/avibactam against metallo-β-lactamase-producing Enterobacterales from the UK: Impact of penicillin-binding protein-3 inserts and CMY-42 β-lactamase in Escherichia coli [PDF]

open access: yesInternational Journal of Antimicrobial Agents, 2023
Aztreonam/avibactam is being developed on the rationale that aztreonam evades metallo-β-lactamases (MBLs) whilst avibactam protects aztreonam against co-produced serine β-lactamases.
David M Livermore   +2 more
exaly   +2 more sources

Hijacking a small plasmid to confer high-level resistance to aztreonam–avibactam and ceftazidime–avibactam

International Journal of Antimicrobial Agents, 2023
Acquired β-lactamase-encoding genes are typically carried by large plasmids in Gram-negative bacteria, which also commonly carry multi-copy small plasmids. This study found that mobile genetic elements carrying antimicrobial resistance genes are capable of hijacking small plasmids. This study focused on aztreonam-avibactam (ATM-AVI) as this combination
Ke Ma   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy